# Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)

> **NCT06259175** · — · COMPLETED · sponsor: **Servier Russia** · enrollment: 396 (actual)

## Conditions studied

- Arterial Hypertension
- HTN

## Interventions

- **DRUG:** Amlodipine 5 mg + indapamide 1.25 mg + perindopril 5 mg
- **DRUG:** Amlodipine 5 mg + indapamide 2.5 mg + perindopril 10 mg
- **DRUG:** Amlodipine 10 mg + indapamide 2.5 mg + perindopril 10 mg

## Key facts

- **NCT ID:** NCT06259175
- **Lead sponsor:** Servier Russia
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-01
- **Primary completion:** 2025-04-21
- **Final completion:** 2025-06-01
- **Target enrollment:** 396 (ACTUAL)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06259175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06259175, "Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06259175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*